acquired
Stage
1
Investors
About
Neon Therapeutics was a biotechnology company developing neoantigen-targeting cancer immunotherapies, including personalized neoantigen vaccines and T cell–based approaches for oncology.
Explore Neon Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.